Assessment of Cardiac Parameters in Evaluation of Cardiac Functions in Patients with Thalassemia Major

REFERENCES

• Arnett EN, Nienhuis AW, Henry WL, Massive myocardial hemosiderosis: a structure-function conference at the National Heart and Lung Institute. Am Heart J. 1975;90:777–787.
   Google Scholar
• Ehlers KH, Giardina PJ, Lesser ML. Prolonged survival in patients with beta-thalassemia major treated with desferrioxamine. J Pediatr. 1991;118:540–545.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ, Clegg JB. Thalassemia: a global public health problem. Nat Med. 1996;3:47–49.
   Google Scholar
• Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The thalassemias. In: Scriver CR, Arthur AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases. New York: Mc, Graw Hill; 2001:4571–4636.
   Google Scholar
• Noori NM, Mehralizadeh S. Echocardiographic evaluation of systolic and diastolic heart function in patients suffering from beta-thalassemia major aged 5–10 years at the Zahedan, Research Center for Children and Adolescent, Health. Anadolu Kardiyol Derg. 2010;10:150–153.
   PubMedGoogle Scholar
• Westwood MA, Anderson LJ, Maceira AM, Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. J Magn Reson Imaging. 2007;25:1147–1151.
   PubMed Web of Science ®Google Scholar
• Ong ML, Hatle LK, Lai VM, Bosco J. Non-invasive cardiac assessment in beta-thalassaemia major. Int J Clin Pract. 2002;56:345–348.
   PubMedGoogle Scholar
• Olivieri NF, Nathan DG, MacMillan JH, Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994 ;331:574–578.
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Wonke B, Prescott E, Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet. 2002;360:516–520.
   PubMed Web of Science ®Google Scholar
• Higgs DR. Gene regulation in hematopoiesis. New lessons from thalassemia. Hematology. 2004;1:1–13.
   Google Scholar
• Cohen AR, Galanello R, Pennell DJ, Thalassemia. Hematology Am Soc Hematol Educ Program. 2004:14–34.
   PubMedGoogle Scholar
• Gurses D, Ulger Z, Levent E, Time domain heart rate variability analysis in patients with thalassaemia major. Acta Cardiol. 2005;60:477–481.
   PubMed Web of Science ®Google Scholar
• Wood JC, Enriquez C, Ghugre N, Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci. 2005;1054:386–395.
   Google Scholar
• Ma QL, Wang B, Fu GH, Heart rate variability in children with beta-thalassemia major. Zhongguo Dang Dai Er Ke Za Zhi. 2011;13:654–656.
   PubMedGoogle Scholar
• Detterich J, Noetzli L, Dorey F, Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol. 2011 Sep 30. doi: 10.1002/ajh.22205. [Epub ahead of print]
   PubMedGoogle Scholar
• Larsen RL, Jakacki RI, Vetter VL, Electrocardiographic changes and arythmias after cancer theraphy in children and young adults. Am J Cardiol. 1992;70:73–77.
   PubMed Web of Science ®Google Scholar
• Sechaud R, Dumortier T, Balez S. Deferasirox does not induce QT/QTc-prolongation in healthy subjects. Int J Clin Pharmacol Ther. 2009;47:321–327.
   PubMedGoogle Scholar
• Wood JC, Enriquez C, Ghugre N, Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci. 2005;1054:386–395.
   PubMed Web of Science ®Google Scholar
• Nussbaum RL, Mclnnes RR, Willard HF. Principles of molecular disease lessons from the hemoglobinopathies. In, Thompson & Thompson Genetics in Medicine. Philadelphia: WB, Saunders; 2001:181–201.
   Google Scholar
• Stein PK, Tereshchenko L, Domitrovich PP, Diastolic dysfunction and autonomic abnormalities in patients with systolic heart failure. Eur J Heart Fail. 2007;9:364–369.
   PubMedGoogle Scholar
• Odemuyiwa O. The relationship between ventricular function and heart rate variability. In: Malik M, Camm AJ, eds. Heart Rate Variability. Armonk, NY: Futura; 1995:241–244.
   Google Scholar
• Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time-domain measurements of heart rate variability. In: Malik M, Camm AJ, eds. Heart Rate Variability. Armonk, NY: Futura; 1995:33–45.
   Google Scholar
• Vybiral T, Glaeser DH. Changes of Heart rate variability preceding ventricular arrhythmias. In: Malik M, Camm AJ, eds. Heart Rate Variability. Armonk, NY: Futura; 1995:421–428.
   Google Scholar
• Yeragani VK, Sobolewski E, Kay J, Effect of age on long-term heart rate variability. Cardiovasc Res. 1997;35:35–42.
   PubMed Web of Science ®Google Scholar
• Ori Z, Singer DH. Changes in heart rate variability associated with sudden cardiac death. In: Malik M, Camm AJ, eds. Heart Rate Variability. Armonk, NY: Futura; 1995:429–449.
   Google Scholar
• Schwartz KA, Li Z, Schwartz DE, Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction. J Appl Physiol. 2002;93:746–751.
   PubMed Web of Science ®Google Scholar
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;13:1043–1064.
   Google Scholar
• Freeman AP, Giles RW, Berdoukas VA, Early left ventricular dysfunction and chelation therapy in thalassemia major. Ann Intern Med. 1983;99:450–454.
   PubMed Web of Science ®Google Scholar
• Hahalis G, Manolis AS, Apostolopoulos D, Right ventricular cardiomyopathy in beta-thalassaemia major. Eur Heart J. 2002;23:147–156.
   PubMed Web of Science ®Google Scholar
• Yaprak I, Aksit S, Ozturk C, Left ventricular diastolic abnormalities in children with β-thalassemia major: a Doppler echocardiography study. Turk J Pediatr. 1998;40:201–209.
   PubMed Web of Science ®Google Scholar
• Vaccari M, Crepaz R, Fortini M, Left ventricular remodeling, systolic function, and diastolic function in young adults with beta-thalassemia intermedia: a Doppler echocardiography study. Chest. 2002;121:506–512.
   PubMed Web of Science ®Google Scholar
• Westwood MA, Anderson LJ, Maceira AM, Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. J Magn Reson Imaging. 2007;25:1147–1151.
   PubMed Web of Science ®Google Scholar
• Bayraktaroğlu S, Aydınok Y, Yıldız D, The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients. Diagn Interv Radiol. 2011;17:346–351.
   PubMed Web of Science ®Google Scholar
• Pennell DJ. T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci. 2005;1054:373–378.
   PubMed Web of Science ®Google Scholar